Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 9.98 -1.58% -0.16
OVID closed down 1.58 percent on Friday, April 20, 2018, on 44 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical OVID trend table...

Date Alert Name Type % Chg
Apr 20 Multiple of Ten Bearish Other 0.00%
Apr 20 Wide Bands Range Expansion 0.00%
Apr 20 Overbought Stochastic Strength 0.00%
Apr 19 180 Bullish Setup Bullish Swing Setup -1.58%
Apr 19 Multiple of Ten Bullish Other -1.58%
Apr 19 Wide Bands Range Expansion -1.58%
Apr 19 Overbought Stochastic Strength -1.58%
Apr 19 Up 3 Days in a Row Strength -1.58%
Apr 19 Up 4 Days in a Row Strength -1.58%
Apr 19 Up 5 Days in a Row Strength -1.58%

Older signals for OVID ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.93
52 Week Low 5.28
Average Volume 126,275
200-Day Moving Average 8.5203
50-Day Moving Average 7.7793
20-Day Moving Average 8.222
10-Day Moving Average 9.239
Average True Range 0.6589
ADX 29.47
+DI 30.44
-DI 10.4
Chandelier Exit (Long, 3 ATRs ) 8.4333
Chandelier Exit (Short, 3 ATRs ) 7.6667
Upper Bollinger Band 10.6315
Lower Bollinger Band 5.8125
Percent B (%b) 0.86
BandWidth 58.611044
MACD Line 0.5913
MACD Signal Line 0.3524
MACD Histogram 0.2389
Fundamentals Value
Market Cap 245.51 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -2.06
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.90
Resistance 3 (R3) 10.94 10.67 10.74
Resistance 2 (R2) 10.67 10.44 10.65 10.69
Resistance 1 (R1) 10.33 10.30 10.20 10.29 10.64
Pivot Point 10.06 10.06 10.00 10.04 10.06
Support 1 (S1) 9.72 9.83 9.59 9.68 9.32
Support 2 (S2) 9.45 9.69 9.43 9.27
Support 3 (S3) 9.11 9.45 9.22
Support 4 (S4) 9.07